In vitro and in vivo evaluation of mutagenicity of fucoxanthin (FX) and its metabolite fucoxanthinol (FXOH)

Journal of Toxicological Sciences

Volumn 34, Issue 6, 2009, Pages 693-698

  Beppu, Fumiaki ^a,b   Niwano, Yoshimi ^a,c   Sato, Emiko ^c   Kohno, Masahiro ^c   Tsukui, Takayuki ^b   Hosokawa, Masashi ^b   Miyashita, Kazuo ^b  

^a Saito Biotechnology Incubator   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Ames test; FX; Marine carotenoid; Micronucleaus test

Indexed keywords

DRUG METABOLITE; FUCOXANTHIN; FUCOXANTHINOL; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BONE MARROW CELL; CONTROLLED STUDY; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; MALE; METABOLIC ACTIVATION; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; SALMONELLA TYPHIMURIUM;

EID: 73849083343     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.693     Document Type: Article

References (21)

1. Ames, B.N., Durston, W.E., Yamasaki, E. and Lee, F.D. (1973): Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. PNAS, 70, 2281-2285.
2. Ames, B.N., Gurney, E.G., Miller, J.A. and Bartsch, H. (1972): Carcinogens as frameshift mutagens: Metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. PNAS, 69, 3128-3132.
3. Asai, A., Sugawara, T., Ono, H. and Nagao, A. (2004): Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites. Drug. Metab. Dispos., 32, 205-211.
4. Asai, A., Yonekura, L. and Nagao, A. (2008): Low bioavailability of dietary epoxyxanthophylls in humans. Br. J. Nutr., 100, 273-277.
5. Beppu, F., Niwano, Y., Tsukui, T., Hosokawa, M. and Miyashita, K. (2009): Single and repeated oral dose toxicity study of fucoxanthin, a marine carotenoid, in mice. J. Toxicol. Sci., 34, 501-510.
6. Das, S.K., Hashimoto, T. and Kanazawa, K. (2008): Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochim. Biophys. Acta., 1780, 743-749.
7. Ishikawa, C., Tafuku, S., Kadekaru, T., Sawada, S., Tomita, M., Okudaira, T., Nakazato, T., Toda, T., Uchihara, J.N., Taira, N., Ohshiro, K., Yasumoto, T., Ohta, T. and Mori, N. (2008): Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int. J. Cancer, 123, 2702-2712.
8. Kadekaru, T., Toyama, H. and Yasumoto, T. (2008): Safety evaluation of fucoxanthin purified from Undaria pinnatifida. Nippon Shokuhin Kagaku Kogaku Kaishi 55, 304-308.
9. Konishi, I., Hosokawa, M., Sashima, T., Kobayashi, H. and Miyashita, K. (2006): Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 142, 53-59.
10. Krishna, G. and Hayashi, M. (2000): In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat. Res., 455, 155-166.
11. MacGregor, J.T., Heddle, J.A., Hite, M., Margolin, B.H., Ramel, C., Salamone, M.F., Tice, R.R. and Wild, D. (1987): Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. Mutat. Res., 189, 103-112.
12. Maeda, H., Hosokawa, M., Sashima, T., Funayama, K. and Miyashita, K. (2005): Fucoxanthin from edible seaweed, Undaria pinnatiflda, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem. Biophys. Res. Commun., 332, 392-397.
13. Maeda, H., Hosokawa, M., Sashima, T. and Miyashita, K. (2007): Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J. Agric. Food Chem., 55, 7701-7706.
14. Sachindra, N.M., Sato, E., Maeda, H., Hosokawa, M., Niwano, Y., Kohno, M. and Miyashita, K. (2007): Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J. Agric. Food Chem., 55, 8516-8522.
15. Satomi, Y. and Nishino, H. (2007): Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. In Vivo, 21, 305-309.
16. Satomi, Y. and Nishino, H. (2009): Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim. Biophys. Acta., 1790, 260-266.
17. Schmid, W. (1975): The micronucleus test. Mutat. Res., 31, 9-15.
18. Shiratori, K., Ohgami, K., Ilieva, I., Jin, X.H., Koyama, Y., Miyashita, K., Yoshida, K., Kase, S. and Ohno, S. (2005): Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp. Eye Res., 81, 422-428.
19. Sugawara, T., Baskaran, V., Tsuzuki, W. and Nagao, A. (2002): Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. J. Nutr., 132, 946-951.
20. Tsukui, T., Konno, K., Hosokawa, M., Maeda, H., Sashima, T. and Miyashita, K. (2007): Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. J. Agric. Food Chem., 55, 5025-5029.
21. Yahagi, T., Nagao, M., Seino, Y., Matsushima, T., Sugimura, T. and Okada, M. (1977): Mutagenesis of N-nitrosamines on salmonella. Mutat. Res., 48, 121-129.